Virtual Investor & Analyst Cell Therapy R&D Day to be held on November 14 at 10 am. Webcast Link Published first on TheFly – the ultimate source for real-time, market-moving
Virtual Investor & Analyst Cell Therapy R&D Day to be held on November 14 at 10 am. Webcast Link Published first on TheFly – the ultimate source for real-time, market-moving
האירוע הזה למשקיעים ואנליסטים יתקיים ב-14 בנובמבר בשעה 10 בבוקר. Webcast Link
Analyst Arthur He CFA of H.C. Wainwright maintained a Buy rating on Poseida Therapeutics (PSTX – Research Report), retaining the price target of $20.00. Arthur He CFA has given his
Poseida Therapeutics, Inc. ( ($PSTX) ) has released its Q3 earnings. Here is a breakdown of the information Poseida Therapeutics, Inc. presented to its investors. Poseida Therapeutics, Inc. is a
Reports Q3 revenue $71.7M, consensus $16.27M. The company expects that its cash, cash equivalents and short-term investments of $230.9M together with these and other remaining near-term milestones and other payments